After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Recently, Yahoo Finance discussed the stock, revealing that Summit Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conference.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Summit Therapeutics Inc is $3.40B. A total of 2.14 million shares were traded on the day, compared to an average of 1.93M shares.
In the most recent transaction, Dhingra Ankur bought 20,400 shares of SMMT for 2.17 per share on Dec 13 ’23. After the transaction, the Chief Financial Officer now owns 254,958 company shares. In a previous transaction on Dec 12 ’23, Zanganeh Mahkam bought 5,000 shares at 2.07 per share. SMMT shares that Chief Executive Officer owns now total 494,814.
Among the insiders who bought shares, Soni Manmeet Singh acquired of 2,976,190 shares on Oct 13 ’23 at a per-share price of $1.68. This resulted in the Chief Operating Officer holding 2,976,190 shares of SMMT after the transaction. In another insider transaction, Zanganeh Mahkam bought 15,973,743 shares at $1.05 per share on Mar 08 ’23. Company shares held by the Co-Chief Executive Officer now total 23,395,269.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, SMMT has a high of $5.22 and a low of $1.25.
As of this writing, SMMT has an earnings estimate of $0 per share for the current quarter. EPS was calculated based on a consensus of 0 estimates, with a high estimate of $0 per share and a lower estimate of $0.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. SMMT’s latest balance sheet shows that the firm has $71.79M in Cash & Short Term Investments as of fiscal 2021. There were $2.78M in debt and $25.62M in liabilities at the time. Its Book Value Per Share was $0.11, while its Total Shareholder’s Equity was $83.28M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SMMT is Buy with a score of 0.00.
